Market revenue in 2024 | USD 1,413.3 million |
Market revenue in 2030 | USD 2,025.0 million |
Growth rate | 6.2% (CAGR from 2025 to 2030) |
Largest segment | Reagents product |
Fastest growing segment | Others Product |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments Product, Reagents Product, Others Product |
Key market players worldwide | Abbott Laboratories, Danaher Corp, BioMerieux SA, Roche Holding AG ADR, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Becton Dickinson & Co, Hologic Inc, Illumina Inc, Grifols SA Ordinary Shares - Class A, Qiagen NV, Siemens Healthineers AG ADR, Sysmex Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to infectious disease molecular diagnostics market will help companies and investors design strategic landscapes.
Reagents product was the largest segment with a revenue share of 67.74% in 2024. Horizon Databook has segmented the China infectious disease molecular diagnostics market based on instruments product, reagents product, others product covering the revenue growth of each sub-segment from 2018 to 2030.
The infectious diseases molecular diagnostics market in China is likely to exhibit a CAGR of xx% during the forecast period. The country’s healthcare policies are focused on developing novel technologies and improving R&D activities to enhance its existing healthcare facilities.
With increasing population, healthcare expenditure in the country is also growing. Increased need for early diagnosis of diseases to reduce treatment costs & mortality rate is expected to boost demand. Several research institutes in China are focused on developing novel technologies for molecular diagnostics.
In addition, a number of private companies are increasingly collaborating with each other or setting up several laboratories across the country. Four major groups of national laboratory chains in China include KingMed, ADICON, Da An, and Lawke.
Horizon Databook provides a detailed overview of country-level data and insights on the China infectious disease molecular diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into China infectious disease molecular diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account